Their mutational pattern showed enrichment in gene involved in oncogenic signaling pathways and in DNA repair, as also found in BRAFV600E melanoma cell lines resistant to BRAF inhibitor in the collection of the Cancer Cell Line Encyclopedia, and in tumors resistant to targeted therapy (26). The gene discussed is BRAF; the disease is melanoma.